Ampersand Biosciences awarded a contract by the NIAID for the development of Ferret Reagents for us in the characterization of immune responses to respiratory infections in the ferret model

Ampersand Biosciences was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID) on July 1, 2020 until August 31, 2022 to address an urgent need to develop reagents to better understand and describe the immunologic analyses of respiratory infections in the ferret. Phase 1 will produce commercially available ferret-specific immunoreagents. Phase 2 will develop Luminex kits for quantitative multiplex analyses of innate immune mediators.

NAICS: 541714 – Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC: AN12 – Health R&D Services; Health Care Services; Applied Research